Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer
Current Oncology · 07.07.2023 · 30 (7) · 6546-6558
DOI: 10.3390/curroncol30070480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 07.07.2023. Verfasst von Yoshihito Kano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Circulating Tumor DNA, Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. The 5-year survival rate after curative resection is almost 80%, however, it is still less than satisfactory for metastatic CRC (mCRC). The combination approach including surgery, chemotherapy, molecular targeted therapy, and immunotherapy is a promising strategy due to its synergistic anticancer effect. Moreover, circulating tumor DNA (ctDNA) analysis has been reported to stratify the post-operative risk of recurrence, thus providing clinically valuable information for deciding to conduct adjuvant chemotherapy. Furthermore, multiple new drugs that potentially target undruggable genes, including KRAS, have been developed. In this review, we discuss the current management of patients with mCRC and future perspectives in the light of a combination therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
- Department of Clinical Research, National Hospital Organization Disaster Medical Center, Tokyo 190-0014, Japan.
ORCID-Profile: Yoshihito Kano
Zitieren
APA
Kano, Y., Suenaga, M., & Uetake, H. (2023). Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer. Current Oncology, 30(7), 6546-6558. https://doi.org/10.3390/curroncol30070480
Vancouver
Kano Y, Suenaga M, Uetake H. Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer. Current Oncology. 2023;30(7):6546-6558. doi:10.3390/curroncol30070480
BibTeX
@article{Kano2023,
author = {Kano, Yoshihito and Suenaga, Mitsukuni and Uetake, Hiroyuki},
title = {Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {7},
pages = {6546--6558},
doi = {10.3390/curroncol30070480}
}
EUVIMED